Inflammatory markers for risk stratification in primary prevention of cardiovascular disease: Time for a 'multimarker' approach?

Thrombosis and Haemostasis

Volumn 95, Issue 3, 2006, Pages 397-398

  Ikonomidis, Ignatios ^a   Lekakis, John ^a   Kremastinos, Dimitrios T ^a  

^a UNIVERSITY OF ATHENS   (Greece)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; BACTERIAL VACCINE; C REACTIVE PROTEIN; COLONY STIMULATING FACTOR 1; CYCLOOXYGENASE 2 INHIBITOR; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; INTERLEUKIN 6; TUMOR NECROSIS FACTOR ALPHA;

ATHEROSCLEROTIC PLAQUE; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CYTOKINE PRODUCTION; EDITORIAL; HEART FAILURE; HEART INFARCTION; HIGH RISK POPULATION; HUMAN; MOLECULAR MECHANICS; PATHOPHYSIOLOGY; PRIORITY JOURNAL; RISK ASSESSMENT; RISK FACTOR; RISK REDUCTION;

BIOLOGICAL MARKERS; C-REACTIVE PROTEIN; CARDIOVASCULAR DISEASES; CORONARY ARTERIOSCLEROSIS; HUMANS; INFLAMMATION; RISK FACTORS; TIME FACTORS; TUMOR NECROSIS FACTOR-ALPHA;

EID: 33645537942     PISSN: 03406245     EISSN: None     Source Type: Journal    
DOI: 10.1160/TH06-02-0073     Document Type: Editorial

References (20)

1. Ross R. Atherosclerosis - An inflammatory disease. N Engl J Med 1999; 340: 115-26.
2. Verma S, et al. C-reactive protein: structure affects function. Circulation 2004; 109: 1914-7.
3. Albert MA, et al. Plasma concentration of C-reactive protein and the calculated Framingham Coronary Heart Disease Risk Score. Circulation 2003; 108: 161-5.
4. Ridker PM, et al. Plasma concentration of IL-6 and the risk of future myocardial infarction among apparently healthy men. Circulation 2000; 101: 1767-72.
5. Pai JK, et al. Inflammatory markers and the risk of coronary heart disease in men and women. N Engl J Med 2004; 351: 2599-610.
6. Cesari M, et al. Inflammatory markers and onset of cardiovascular events: results from the Health ABC study. Circulation 2003; 108: 2317-22.
7. Tuomisto K, et al. C-reactive protein and tumor necrosis factor as predictors of incident coronary and cardiovascular events and total mortality. A population -based prospective study. Thromb Haemost 2006; 95: 511-8.
8. Ikonomidis I, et al. Increased circulating C-reactive protein and macrophage-colony stimulating factor are complementary predictors of long-term outcome in patients with chronic coronary artery disease. Eur Heart J 2005; 26: 1618-24.
9. Stollenwerk MM, et al. Very low density lipoprotein potentiates tumor necrosis factor-alpha expression in macrophages. Atherosclerosis 2005; 179: 247-54.
10. Bataille R, Klein B. C-reactive protein levels as a direct indicator of interleukin 6 levels in humans in vivo. Arthritis Rheum 1992; 35: 982-4.
11. Geng Y J, et al. Apoptosis of vascular smooth muscle cells induced by in vitro stimulation with interferon-γ, tumor necrosis factor-α, and interleukin-1 β. Arterioscler Thromb Vasc Biol 1996; 16: 19-27.
12. Barath P, et al. Tumor necrosis factor gene expression in human vascular intimal smooth muscle cells detected by in situ hybridization Am J Pathol 1990; 137: 503-9.
13. Reynolds GD, Vance RR. C-reactive protein immunohistochemical localisation in normal and atherosclerotic human aortas. Arch Pathol Lab Med 1987; 111:265-9.
14. Kip KE, et al. Global inflammation predicts cardiovascular risk in women: a report from the Women's Ischemia Syndrome Evaluation (WISE) study. Am Heart J 2005; 150: 900-6.
15. Imhof A, et al. Effect of alcohol consumption on systemic markers of inflammation. Lancet 2001; 357: 763-7.
16. Singh U, et al. Vitamin E, oxidative stress, and inflammation. Annu Rev Nutr 2005; 25: 151-74.
17. Smith SC, et al. CDC/AHA Workshop on markers of inflammation and cardiovascular disease: Application to clinical and public health practice: report from the clinical practice discussion group. Circulation 2004; 110: 550-3.
18. Vlachopoulos C, et al. Acute systemic inflammation increases arterial stiffness and decreases wave reflections in healthy individuals. Circulation 2005; 112: 2193-200.
19. Vasan RS, et al. Inflammatory markers and risk for heart failure in elderly subjects without prior myocardial infarction. The Framingham Heart Study. Circulation 2003; 107: 1486-91.
20. Ikonomidis I, et al. Myocardial ischemia induces interleukin 6 and tissue factor production in patients with coronary artery disease. A dobutamine stress echocardiography study. Circulation 2005; 112: 3272-9.